Mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefor
[Problems] To provide a novel mixture for assaying a target nucleic acid, characterized by enabling a nucleic acid assay while: 1) requiring no step of diluting the target nucleic acid; 2) requiring no procedure of changing a probe concentration depending on a concentration of the target nucleic acid. [Means for Solving Problems] 1) A mixture which comprises one internal standard nucleic acid and two nucleic acid probes labeled with a fluorescent dye; 2) a mixture for measuring Km value which comprises one internal standard nucleic acid having a partial mutation and one nucleic acid probe labeled with a fluorescent dye; 3) a mixture which comprises one internal standard nucleic acid and one double nucleic acid probe labeled with two fluorescent dyes; and a method for assaying a nucleic acid by making use thereof.
1. A method for assaying a target nucleic acid in a sample, which comprises:
(I) adding (i) a fluorescence-quenching probe to the sample, wherein the fluorescence-quenching probe (i) has, as one of end bases thereof, a cytosine which is labeled with a first fluorescence-quenching dye, and the fluorescence-quenching probe (i) is hybridizable with the target nucleic acid and is designed such that at least one guanine exists in the target nucleic acid at a position of from a 1st base to a 3rd base, with the proviso that a base, which is base-paired with the cytosine, is counted as the 1st base, and
wherein the first fluorescence-quenching dye is selected from the group consisting of 2′,4,7,7′-tetra-chlorofluorescein, TBSF, 2′,4,4′,5′,7,7′-hexachlorofluorescein, R6G and 2-oxo-6,8-difluoro-7-hydroxy-2H-1-benzopyran-3-carboxylic acid,
(II) maintaining the sample under conditions that the fluorescence-quenching probe (i) is hybridizable with the target nucleic acid, and measuring fluorescence derived from the fluorescence-quenching probe (i),
(III) maintaining the sample under conditions that the fluorescence-quenching probe (i) is not hybridizable with the target nucleic acid, and measuring fluorescence derived from the fluorescence-quenching probe (i), and
(IV) assaying the target nucleic acid in the sample from fluorescent intensities determined in the step (II) and step (III),
wherein the fluorescence-quenching probe (i) have cytosines as both the end bases, and the end base different from the one end base is labeled with a second fluorescence-quenching dye different from the first fluorescence-quenching dye.
2. The method according to claim 1 , wherein the step (II) to step (IV) are conducted by a real-time monitoring, quantitative PCR method.
3. The method according to claim 1 , wherein the second fluorescence-quenching dye is selected from the group consisting of 2′,4,7,7′-tetra-chlorofluorescein, TBSF, 2′,4,4′,5′,7,7′-hexachlorofluorescein, R6G, 2-oxo-6,8-difluoro-7-hydroxy-2H-1-benzopyran-3-carboxylic acid, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid and Carboxytetramethylrhodamine.
4. The method according to claim 1 , wherein the target nucleic acid is a gene amplification product.
5. The method according to claim 1 , wherein the target nucleic acid is a gene amplification product amplified by a method selected from a PCR method, LCR method, TAS method, ICAN method, LAMP method, NASBA method, RCA method, TAMA method and UCAN method.
6. A method for assaying, at the same time, a first and second target nucleic acid in a sample, which comprises:
(I) adding (i) a first fluorescence-quenching probe and (ii) a second fluorescence-quenching probe to the sample,
wherein the first fluorescence-quenching probe (i) has, as one of end bases thereof, a cytosine which is labeled with a first fluorescence-quenching dye, and the first fluorescence-quenching probe (i) is hybridizable with the first target nucleic acid and is designed such that a guanine exists in the first target nucleic acid at a position that is base-paired with the cytosine,
wherein the second fluorescence-quenching probe (ii) has, as one of end bases thereof, a cytosine which is labeled with a second fluorescence-quenching dye different from the first fluorescence-quenching dye, and the second fluorescence-quenching probe (ii) is hybridizable with the second target nucleic acid and is designed such that a guanine exists in the second target nucleic acid that is base-paired with the cytosine, and
wherein the first fluorescence-quenching dye is selected from the group consisting of 2-oxo-6,8-difluoro-7-hydroxy-2H-1-benzopyran-3-carboxylic acid,
(II) maintaining the sample under conditions that the first and second fluorescence-quenching probes (i) and (ii) are hybridizable with the first and second target nucleic acids, respectively, and measuring fluorescence derived from the first fluorescence-quenching probe (i) and fluorescence derived from the second fluorescence-quenching probe (ii),
(III) maintaining the sample under conditions that the first and second fluorescence-quenching probes (i) and (ii) are not hybridizable with the first and second target nucleic acids, respectively, and measuring fluorescence derived from the first fluorescence-quenching probe (i) and fluorescence derived from the second fluorescence-quenching probe (ii), and
(IV) assaying the first and second target nucleic acids in the sample from fluorescent intensities determined in the step (II) and step (III).
7. The method according to claim 6 , wherein the second fluorescence-quenching dye with which the second fluorescence-quenching probe (ii) is labeled is selected from the group consisting of 2′,4,7,7′-tetra-chlorofluorescein, TBSF, 2′,4,4′,5′,7,7′-hexachlorofluorescein, R6G, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid and Carboxytetramethylrhodamine.
8. The method according to claim 6 , wherein the first and second target nucleic acids are gene amplification products, respectively.
9. The method according to claim 6 , wherein the first and second target nucleic acids are gene amplification products, respectively, which have been amplified by a method selected from a PCR method, LCR method, TAS method, ICAN method, LAMP method, NASBA method, RCA method, TAMA method and UCAN method.
10. A method for assaying a target nucleic acid in a sample, which comprises:
(I) adding (i) a fluorescence-quenching probe to the sample, wherein the fluorescence-quenching probe (i) has, as one of end bases thereof, a cytosine which is labeled with a first fluorescence-quenching dye, and the fluorescence-quenching probe (i) is hybridizable with the target nucleic acid and is designed such that a guanine exists in the target nucleic acid at a position that is base-paired with the cytosine, and
wherein the first fluorescence-quenching dye is 2-oxo-6,8-difluoro-7-hydroxy-2H-1-benzopyran-3-carboxylic acid,
(II) maintaining the sample under conditions that the fluorescence-quenching probe (i) is hybridizable with the target nucleic acid, and measuring fluorescence derived from the fluorescence-quenching probe (i),
(III) maintaining the sample under conditions that the fluorescence-quenching probe (i) is not hybridizable with the target nucleic acid, and measuring fluorescence derived from the fluorescence-quenching probe (i), and
(IV) assaying the target nucleic acid in the sample from fluorescent intensities determined in the step (II) and step (III).
11. The method according to claim 10 , wherein the step (II) to step (IV) are conducted by a real-time monitoring, quantitative PCR method.
12. The method according to claim 10 , wherein the fluorescence-quenching probe (i) have cytosines as both the end bases, and the end base different from the one end base is labeled with a second fluorescence-quenching dye different from the first fluorescence-quenching dye.
13. The method according to claim 12 , wherein the second fluorescence-quenching dye is selected from the group consisting of 2′,4,7,7′-tetra-chlorofluorescein, TBSF, 2′,4,4′,5′,7,7′-hexachlorofluorescein, R6G, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid and Carboxytetramethylrhodamine.
14. The method according to claim 10 , wherein the target nucleic acid is a gene amplification product.
15. The method according to claim 10 , wherein the target nucleic acid is a gene amplification product amplified by a method selected from a PCR method, LCR method, TAS method, ICAN method, LAMP method, NASBA method, RCA method, TAMA method and UCAN method.